Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

373 trials

NCT04478838
Recruiting
"Extended" (Alternate Day) Antipsychotic Dosing
Phase 4 · Canada · 1 site
Registry update: 13 Apr 2026
NCT05276050
Recruiting
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Not applicable · United States · 1 site
Registry update: 16 Sept 2026
NCT04411225
Recruiting
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
Phase 3 · United States · 2 sites
Registry update: 8 Jan 2026
NCT04945278
Recruiting
Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
Not applicable · France · 1 site
Registry update: 19 Mar 2026
NCT05590637
Recruiting
Comparing Antipsychotic Medications in LBD Over Time
Phase 4 · United States · 2 sites
Registry update: 9 Sept 2025
NCT05445180
Recruiting
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Not applicable · Canada · 1 site
Registry update: 15 Sept 2026
NCT05127278
Recruiting
E-Detection Tool for Emerging Mental Disorders
Not applicable · United Kingdom · 2 sites
Registry update: 29 Nov 2024
NCT05282277
Recruiting
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Phase 4 · United States · 1 site
Registry update: 29 Apr 2026
NCT05036590
Recruiting
Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.
Not applicable · France · 1 site
Registry update: 12 Jun 2026
NCT05208190
Recruiting
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Phase 4 · United States · 7 sites
Registry update: 4 May 2026
NCT05299749
Recruiting
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
Not applicable · United States · 1 site
Registry update: 18 Sept 2025
NCT04580134
Recruiting
CLOZAPINE Response in Biotype-1
Phase 4 · United States · 5 sites
Registry update: 11 May 2026
NCT05349513
Recruiting
Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders
Not applicable · France · 1 site
Registry update: 23 Oct 2026
NCT05240976
Recruiting
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
Phase 2 · Taiwan · 1 site
Registry update: 24 Mar 2026
NCT04226898
Recruiting
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Phase 2 · United States · 1 site
Registry update: 7 Apr 2026
NCT05185128
Recruiting
Neural Basis of Social Cognition Deficits
Not applicable · United States · 1 site
Registry update: 4 Feb 2026
NCT04887792
Recruiting
Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/2 · India, United States · 2 sites
Registry update: 7 Jul 2026
NCT05184335
Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Phase 3 · United States · 17 sites
Registry update: 19 Dec 2024
NCT05159349
Recruiting
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia
Not applicable · China · 1 site
Registry update: 8 Jun 2026
NCT06340789
Recruiting
Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
Phase 2 · Taiwan · 1 site
Registry update: 16 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.